Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
The new shadow roll-on delivers strong on-shelf presence with its modern rounded-base design
Nearly 1 in 3 HbA1c test results fall within the diabetic range, while 1 in 4 individuals show signs of prediabetes
The inclusion of broad-spectrum sunscreen in the WHO EML and EMLc follows an application submitted in November 2024 by the Global Albinism Alliance
VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
The expanded approval allows Kerendia to be prescribed to heart failure patients with a LVEF of 40% or more
From material selection to cooling tower management, every small decision affects long-term equipment reliability
Capvaxive has recorded $530 million in cumulative sales over its first four quarters on the market
Subscribe To Our Newsletter & Stay Updated
